Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

SAN-09611: Prospective Single-Timepoint Huntington's Disease Biospecimen Collection Study

NCT05773196 is registered in ClinicalTrials.gov with Sanguine Biosciences as lead sponsor.

NCT NCT05773196
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05773196 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
SAN-09611: Prospective Single-Timepoint Huntington's Disease Biospecimen Collection Study
Lead sponsor
Sanguine Biosciences
Phase
Observational
Overall status
Unknown status
Start date
March 14, 2023
Completion date
February 28, 2025
Enrollment
5 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

huntington disease, huntington disease, late onset, huntington's dementia, huntington; dementia (etiology)